Vascular density is a predictor of cancer-specific survival in prostatic carcinoma

Prostate

Volumn 33, Issue 1, 1997, Pages 38-45

  Lissbrant, Ingela Franck ^a   Stattin, Par ^a   Damber, Jan Erik ^a   Bergh, Anders ^a  

^a UMEÅ UNIVERSITY   (Sweden)

Author keywords

Anglogenesis; Prognosis; Prostate

Indexed keywords

ADULT; AGED; ANGIOGENESIS; ARTICLE; CANCER SURVIVAL; DIAGNOSTIC VALUE; HUMAN; HUMAN TISSUE; MALE; PRIORITY JOURNAL; PROSTATE CARCINOMA; TUMOR BLOOD FLOW;

AGED; AGED, 80 AND OVER; BLOOD VESSELS; CARCINOMA; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MICROCIRCULATION; MIDDLE AGED; PROGNOSIS; PROSTATIC NEOPLASMS; SURVIVAL ANALYSIS;

EID: 0030866894     PISSN: 02704137     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0045(19970915)33:1<38::AID-PROS7>3.0.CO;2-5     Document Type: Article

References (41)

1. Boyle P, Maisonneuve P, Napalkov P: Geographical and temporal patterns of incidence and mortality from prostate cancer. Urology 1995;46:47-55.
2. Pedersen KV, Herder A: Radical retropubic prostatectomy for localised prostatic carcinoma: A clinical and pathological study of 201 cases. Scand J Urol Nephrol 1993;27:219-224.
3. Moreno JG, Ahlering TE: Late local complications after definitive radiotherapy for prostatic adenocarcinoma. J Urol 1992;147: 926-928.
4. Gleason DF, Mellinger GT: Prediction of prognosis for prostatic adenocarcinoma by combined histological grading and clinical staging. J Urol 1974;111:58-64.
5. Oesterling JE: Prostate specific antigen: A critical assessment of the most useful tumor marker for adenocarcinoma of the prostate. J Urol 1991;145:907-923.
6. Weidner N, Folkman J, Pozza F, Bevilacqua P, Allred EN, Moore DH, Meli S, Gasparini G: Tumor angiogenesis: A new significant and independent indicator in early-stage breast carcinoma. JNC 1992;84:1875-1887.
7. Srivastava A, Laidler P, Davies RP, Horgan K, Hughes LE: The prognostic significance of tumor vascularity in intermediate-thickness (0.76-4.0 mm thick) skin melanoma. A quantitative histologic study. Am J Pathol 1988;133:419-423.
8. Fontanini G, Bigini D, Vignati S, Basolo F, Mussi A, Lucchi M, Chine S, Angeletti CA, Harris AL, Bevilacqua G: Microvessel count predicts metastatic disease and survival in non-small cell lung cancer. J Pathol 1995;177:57-63.
9. Olivarez D, Ulbright T, DeRiese W, Foster R, Reister T, Einhorn L, Sledge G: Neovascularization in clinical stage A testicular germ cell tumor: Prediction of metastatic disease. Cancer Res 1994;54:2800-2802.
10. Hollingsworth HC, Kohn EC, Steinberg SM, Rothenberg ML, Merino MJ: Tumor angiogenesis in advanced stage ovarian carcinoma. Am J Pathol 1995;147:33-41.
11. Weidner N, Carroll PR, Flax J, Blumenfeld W, Folkman J: Tumor angiogenesis correlates with metastasis in invasive prostate carcinoma. Am J Pathol 1993;143:401-409.
12. Folkman J: What is the evidence that tumors are angiogenesis dependent? JNC 1990;82:4-6.
13. Folkman J: Tumor angiogenesis. In Mendelsohn J, Howley PM, Israel MA, Liotta LA (eds): "The Molecular Basis of Cancer," Philadelphia: W.B. Saunders Company, 1995:206-224.
14. Folkman J, Watson K, Ingber D, Hanahan D: Induction of angiogenesis during the transition from hyperplasia to neoplasia. Nature 1989;339:58-61.
15. Folkman J: Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med 1995;1:27-31.
16. Fidler IJ, Ellis LM: The implications of angiogenesis for the biology and therapy of cancer metastasis. Cell 1994;79:185-188.
17. Dvorak HF, Nagy JA, Dvorak JT, Dvorak AM: Identification and characterization of the blood vessels of solid tumors that are leaky to circulating macro molecules. Am J Pathol 1988;133:95-109.
18. Gross JL, Moscatelli D, Rifkin DB: Increased capillary endothelial cell protease activity in response to angiogenic stimuli in vitro. Proc Natl Acad Sci USA 1983;80:2623-2627.
19. Liotta LA, Kleinerman J, Saidel GM: Quantitative relationships of intravascular tumor cells, tumor vessels, and pulmonary metastases following tumor implantation. Cancer Res 1974;34:997-1004.
20. Siegal JA, Yu E, Brawer MK: Topography of neovascularity in human prostate carcinoma. Cancer 1995;75:2545-2551.
21. Brawer MK, Bigler SA, Deering RE: Quantitative morphometric analysis of the microcirculation in prostate carcinoma. J Cell Biochem [Suppl] 1992;16:62-64.
22. Bigler SA, Deering RE, Brawer MK: Comparison of microscopic vascularity in benign and malignant prostate tissue. Hum Pathol 1993;24:220-226.
23. Fregene TA, Khanuja PS, Noto AC, Gehani SK, Van Egmont EM, Luz DA, Pienta KJ: Tumor-associated angiogenesis in prostate cancer. Anticancer Res 1993;13:2377-2381.
24. Furusato M, Wakui S, Sasaki H, Ito K, Ushigome S: Tumour angiogenesis in latent prostatic carcinoma. Br J Cancer 1994;70: 1244-1246.
25. Brawer MK, Deering RE, Browne M, Preston SD, Bigler SA: Predictors of pathologic stage in prostatic carcinoma. The role of neovascularity. Cancer 1994;73:678-687.
26. Salomao DR, Graham SD, Bostwick DG: Microvascular invasion in prostate cancer correlates with pathologic stage. Arch Pathol Lab Med 1995;119:1050-1054.
27. Wakui S, Furusato M, Itoh T, Sasaki H, Akiyama A, Kinoshita I, Asano K, Tokuda T, Aizawa S, Ushigome S: Tumor angiogenesis in prostatic carcinoma with and without bone marrow metastasis: A morphometric study. J Pathol 1992;168:257-262.
28. Union Internationale Contre le Cancer (UICC): "TNM Classification of Prostate Tumours," 2nd ed. Berlin: Springer, 1978.
29. Mostofi FK, Sesterhenn IA, Sobin LH: "International Histological Classification of Prostate Tumours," Geneva: WHO, 1980.
30. Taylor CR, Shi SR, Chaiwun B, Young L, Imam SA, Cote RJ: Strategies for improving the immunohistochemical staining of various intranuclear prognostic markers in formalin-paraffin sections: Androgen receptor, estrogen receptor, progesterone receptor, p53 protein, proliferating cell nuclear antigen, and Ki-67 antigen revealed by antigen retrieval techniques. Hum Pathol 1994;25:263-270.
31. Weibel ER: "Stereological Methods, Vol 1: Practical Methods for Biological Morphometry," London: Academic Press, 1979.
32. Partin AW, Coffey DS: Benign and malignant prostatic neoplasms: Human studies. Recent Prog Horm Res 1994;49:293-331.
33. Grönberg H, Bergh A, Damber J-E, Jonsson H, Lenner P, Ångström T: Prostate cancer in northern Sweden. Incidence, survival and mortality in relation to tumour grade. Acta Oncol 1994;33:359-363.
34. Weidner N: Intratumor microvessel density as a prognostic factor in cancer. Am J Pathol 1995;147:9-19.
35. Craft PS, Harris AL: Clinical prognostic significance of tumour angiogenesis. Ann Oncol 1994;5:305-311.
36. Weidner N: Current pathologic methods for measuring intratumoral microvessel density within breast carcinoma and other solid tumors. Breast Cancer Res Treat 1995;36:169-180.
37. Axelsson K, Ljung BE, Moore DH II, Thor AD, Chew KL, Edgerton SM, Smith HS, Mayall BH: Tumor angiogenesis as a prognostic assay for invasive ductal breast carcinoma. JNCI 1995;87: 997-1008.
38. Barbareschi M, Gasparini G, Morelli L, Forti S, Dalla Palma P: Novel methods for the determination of the angiogenic activity of human tumors. Breast Cancer Res Treat 1995;36:181-192.
39. Vartanian RK, Weidner N: Correlation of intratumoral endothelial cell proliferation with microvessel density (tumor angiogenesis) and tumor cell proliferation in breast carcinoma. Am J Pathol 1994;144:1188-1194.
40. Fox SB, Gatter KC, Bicknell R, Going JJ, Stanton P, Cooke TG, Harris AL: Relationship of endothelial cell proliferation to tumor vascularity in human breast cancer. Cancer Res 1993;53: 4161-4163.
41. Vartanian RK, Weidner N: Endothelial cell proliferation in prostatic carcinoma and prostatic hyperplasia: Correlation with Gleason's score, microvessel density, and epithelial cell proliferation. Lab Invest 1995;73:844-850.